The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study

被引:18
|
作者
Dunleavy, Karen [1 ]
Hope, Vivian [2 ]
Roy, Kirsty [3 ]
Taylor, Avril [1 ]
机构
[1] Univ West Scotland, Sch Media Culture & Soc, Paisley PA1 2BE, Renfrew, Scotland
[2] Liverpool John Moores Univ, Publ Hlth Inst, Liverpool, Merseyside, England
[3] NHS Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland
关键词
People who inject drugs; Skin and soft tissue infections; Abscesses; Cellulitis; Harm reduction; Public health intervention; SAFER ENVIRONMENT INTERVENTIONS; HEPATITIS-C; USERS; RISK; PROGRAM; CARE; ETHYLPHENIDATE; INCREASE; BEHAVIOR; INJURY;
D O I
10.1016/j.drugpo.2018.09.001
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Bacterial skin and soft tissue infections (SSTI) among people who inject drugs (PWID) are considered a public health concern. There is a lack of qualitative research examining the lived experience of PWID who have had SSTI. This paper explores PWID views and experiences of their SSTI, their perceptions on the causes of their SSTI and their harm reduction (HR) behaviours. The implications for HR service delivery and practice will be discussed. Methods: Between October 2015 January 2016, 22 in-depth interviews were conducted with PWID who had experienced a SSTI within the past year. Interviewees were recruited from an injecting equipment provision service and a drug treatment service in Glasgow and Edinburgh respectively. The interview transcripts were transcribed verbatim and underwent thematic analysis. Results: We found that the experience of SSTI can cause strong negative feelings, including panic and stigma and that there was limited knowledge of SSTI prior to first hand experience. The awareness of the unacceptable social and physical consequences of SSTI fostered a sense of personal responsibility and agency which led to the introduction or improved HR uptake. However, when PWID were struggling to inject or when their physical and political environments were compromised there was an increased risk for SSTI and reduced effectiveness of HR. Conclusion: Compared to HCV and HIV, SSTI as an injecting related harm has received less policy attention. Policy makers need to address SSTI HR within enabling environments, such as 'safer environment interventions'. It is recommended that peer based support, improved NSP provision and medically supervised injecting facilities are needed to deliver SSTI HR.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 50 条
  • [21] Epidemiology of acute infections in people who inject drugs in Australia
    Attwood, Lucy O.
    O'Keefe, Daniel
    Higgs, Peter
    Vujovic, Olga
    Doyle, Joseph S.
    Stewardson, Andrew J.
    DRUG AND ALCOHOL REVIEW, 2024, 43 (01) : 304 - 314
  • [22] ‘Care and Prevent’: rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London
    M. Harris
    R. Brathwaite
    Catherine R. McGowan
    D. Ciccarone
    G. Gilchrist
    M. McCusker
    K. O’Brien
    J. Dunn
    J. Scott
    V. Hope
    Harm Reduction Journal, 15
  • [23] 'Safer environment interventions': A qualitative synthesis of the experiences and perceptions of people who inject drugs
    McNeil, Ryan
    Small, Will
    SOCIAL SCIENCE & MEDICINE, 2014, 106 : 151 - 158
  • [24] Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study
    Wheeler, Alice
    Valerio, Heather
    Cunningham, Evan B.
    Martinello, Marianne
    Barocas, Joshua A.
    Colledge-Frisby, Samantha
    Treloar, Carla
    Amin, Janaki
    Henderson, Charles
    Read, Phillip
    Matthews, Gail V.
    Dunlop, Adrian J.
    Gorton, Carla
    Hayllar, Jeremy
    Alavi, Maryam
    Murray, Carolyn
    Marks, Phillipa
    Silk, David
    Degenhardt, Louisa
    Dore, Gregory J.
    Grebely, Jason
    behalf ETHOS Engage Study Grp
    DRUG AND ALCOHOL DEPENDENCE, 2022, 237
  • [25] Impact of funding harm reduction programs for people who inject drugs in Mexico
    Valenzuela-Lara, Marisol
    Ponce-Ramos, Marisol
    Ruiz-Herrera, Karen
    Lopez-Gonzalez, Agustin
    SALUD MENTAL, 2019, 42 (04) : 157 - 163
  • [26] The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs
    B. Morgan
    R. Lancaster
    B. Boyagoda
    R. Ananda
    LO Attwood
    D. Jacka
    I. Woolley
    BMC Infectious Diseases, 24
  • [27] Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs
    Allen, Sean T.
    Grieb, Suzanne M.
    O'Rourke, Allison
    Yoder, Ryan
    Planchet, Elise
    White, Rebecca Hamilton
    Sherman, Susan G.
    HARM REDUCTION JOURNAL, 2019, 16 (1)
  • [28] Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based Approach study
    Kesten, Joanna
    Hussey, Deborah
    Lord, Catherine
    Roberts, Leonie
    Bayliss, James
    Erswell, Helen
    Preston, Andrew
    Telfer, Maggie
    Scott, Jenny
    Harris, Magdalena
    Mellon, Dominic
    Hickman, Matthew
    MacArthur, Georgie
    Fisher, Harriet
    HARM REDUCTION JOURNAL, 2023, 20 (01)
  • [29] Predictors of skin and soft tissue infections among sample of rural residents who inject drugs
    Amelia Baltes
    Wajiha Akhtar
    Jen Birstler
    Heidi Olson-Streed
    Kellene Eagen
    David Seal
    Ryan Westergaard
    Randall Brown
    Harm Reduction Journal, 17
  • [30] A call for training graduate medical students on harm reduction for people who inject drugs
    Jawa, Raagini
    Saravanan, Nivetha
    Burrowes, Shana A. B.
    Demers, Lindsay
    SUBSTANCE ABUSE, 2021, 42 (03) : 266 - 268